Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'

J Psychopharmacol. 2001 Jun;15(2):139-41. doi: 10.1177/026988110101500210.

Abstract

We report two patients who developed a severe discontinuation (withdrawal) reaction following stoppage of paroxetine and venlafaxine, respectively. Neurological symptoms were prominent and neither patient could walk unaided. Both patients feared they had suffered a 'stroke' and arranged an emergency medical consultation. One patient was correctly diagnosed, the antidepressant was recommenced and symptoms resolved within 24 h. Failure to recognize the reaction resulted in the other patient being referred to a neurologist, undergoing a computed tomography brain scan and an electroencephalogram and remaining symptomatic for over 8 weeks. Relevant pharmacological issues are discussed. The cases illustrate the importance of patients and clinicians being familiar with antidepressant discontinuation symptoms.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antidepressive Agents / adverse effects*
  • Antidepressive Agents, Second-Generation / adverse effects
  • Cyclohexanols / adverse effects
  • Diagnosis, Differential
  • Dysthymic Disorder / drug therapy
  • Dysthymic Disorder / psychology
  • Female
  • Humans
  • Paroxetine / adverse effects
  • Stroke / diagnosis*
  • Substance Withdrawal Syndrome / diagnosis
  • Substance Withdrawal Syndrome / psychology*
  • Venlafaxine Hydrochloride

Substances

  • Antidepressive Agents
  • Antidepressive Agents, Second-Generation
  • Cyclohexanols
  • Paroxetine
  • Venlafaxine Hydrochloride